Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$3.97M Sell
115,198
-643
-0.6% -$21.7K 1.71% 18
2015
Q3
$3.49M Sell
115,841
-740
-0.6% -$21.4K 1.61% 22
2015
Q2
$3.55M Sell
116,581
-29,353
-20% -$949K 1.41% 28
2015
Q1
$4.56M Sell
145,934
-2,263
-2% -$76.4K 1.81% 18
2014
Q4
$5.38M Sell
148,197
-11,100
-7% -$386K 2.22% 11
2014
Q3
$5.55M Sell
159,297
-680
-0.4% -$23K 2.23% 7
2014
Q2
$4.94M Buy
159,977
+442
+0.3% +$12.1K 1.97% 11
2014
Q1
$4.12M Sell
159,535
-5,702
-3% -$142K 1.73% 20
2013
Q4
$4.29M Sell
165,237
-1,750
-1% -$42.3K 1.69% 22
2013
Q3
$3.83M Buy
166,987
+9,762
+6% +$225K 1.62% 25
2013
Q2
$3.81M Buy
+157,225
New +$3.71M 1.72% 22

Other funds holding INTC

Aspiriant Holdings S3's INTC Position: Q4 2015 in Review

Aspiriant Holdings S3 reduced its Intel (INTC) stake by 0.56% in Q4 2015, selling an estimated $21.7K and leaving 115,198 shares worth $3.97M. The position accounts for 1.71% of the portfolio, ranked #18.

Aspiriant Holdings S3 first reported a position in INTC in Q2 2013 and has held it in 11 quarters since. The position peaked at $5.55M in Q3 2014. 1,796 funds tracked by Wall St. Rank hold INTC as of Q4 2015.

  • Aspiriant Holdings S3 held 115,198 shares of Intel worth $3.97M as of Q4 2015.
  • Aspiriant Holdings S3 sold 643 Intel shares in Q4 2015, an estimated $21.7K.
  • Intel made up 1.71% of Aspiriant Holdings S3's portfolio in Q4 2015, its #18 holding.
  • Aspiriant Holdings S3 first reported a position in Intel in Q2 2013 and has held it in 11 quarters since.
  • Aspiriant Holdings S3's Intel position peaked at $5.55M in Q3 2014.
  • 1,796 funds tracked by Wall St. Rank held Intel as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.